Biophytis Initiates Early Access Authorization from French National Authority for Health (HAS) for Treatment of Severe COVID-19 with Sarconeos
Biophytis SA ((NasdaqCM: BPTS, PARIS:ALBPS) (the "Company" or "Biophytis"), a biotechnology company focused on the development of drugs to slow the degenerative processes associated with aging,